Preliminary assessment of the safety of glucocorticoids during pregnancy on the offspring

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049880

Enrollment

Unknown

Registered

2021-08-10

Start date

2021-08-10

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy

Interventions

Experimental group:Glucocorticoids

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women who use glucocorticoids during pregnancy (including exposure to glucocorticoid alone, and exposure to glucocorticoids and other drugs in two subgroups); 2. Pregnant women who volunteered to participate in the survey with informed consent.

Exclusion criteria

Exclusion criteria: Pregnant women with mental illness or physical disability who can't participate in this study.

Design outcomes

Primary

Measure	Time frame
congenital defect;spontaneous abortion;induced abortion;adverse events of fetus;premature labour;adverse events of neonatus;birth weight;Apgar scores;adverse events of children;	—

Countries

China

Contacts

Public ContactZheng Caihong

Women's Hospital, School of Medicine Zhejiang University

chzheng@zju.edu.cn+86 571 89991730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026